Antibiotics and probiotics in acute pancreatitis

Česká verzia

Authors: J. Lata; O. Stibůrek
Authors place of work: Interní hepatogastroenterologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MU Dr. Jan Lata, CSc.
Published in the journal: Vnitř Lék 2010; 56(6): 582-584
Category: 65th Birthday - Petr Svacina, MD

Summary

Severe acute pancreatitis is serious disease. High mortality is also due to infection complications. If we will be able to prevent the infection, it could diminish mortality. The role of prevention of infection with antibiotics and probiotics is discussed in the paper.

Key words:
acute pancreatitis – antibiotics – probiotics

Zdroje

1. Neoptolemos JP, Raraty M, Finch M et al. Acute pancreatitis: the substantial human and financial costs. Gut 1998; 42: 886– 891.

2. Isenmann R, Rünzi M, Kron M et al. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo‑ controlled, double‑blind trial. Gastroenterology 2004; 126: 997– 1004.

3. Mazaki T, Ishii Y, Takayama T. Meta‑analysis of prophylactic antibiotic use in acute necrotizing pancreatitis. Br J Surg 2006; 93: 674– 678.

4. Špičák J, Hejtmánková S, Hubaczová M et al. Antibiotická profylaxe infekčních komplikací u akutní pankreatitidy – výsledky randomizované studie s meropenemem. Čes Slov Gastroent Hepatol 2003; 57: 222– 227.

5. Powell JJ, Campbell E, Johnson CD et al. Survey of antibiotic prophylaxis in acute pancreatitis in the UK and Ireland. Br J Surg 1999; 86: 320– 322.

6. Banks BA, Freeman ML. Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006; 101: 2379– 2400.

7. Working Party of the British Society of Gastroenterology. UK guidelines for the management of acute pancreatitis. Gut 2005; 54 (Suppl 3): iii1– iii9.

8. Cahn DR. Über die nach Gram färbbaren Bacillen des Säulingsstuhles (Bacilli of infant stools stainable according to Gram.) Centralblatt für Bakteriologie I. Abteilung Originale 1901; 30: 721– 726.

9. Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989; 66: 365– 378.

10. Lilly DM, Stillwell RH. Probiotics: growth‑ promoting factors produced by microorganisms. Science 1965; 147: 747– 748.

11. Havenaar R, Ten Brink B, Huis in’t Veld JH. Selection of strains for probiotic use. In: Fuller R (ed). Probiotics: the scientific basis. London: Chapman and Hall 1992: 209– 224.

12. Döderlein A. Das Scheidensekret und seine Bedeutung für das Puerperalfieber (The vaginal transsudate and its significance for childbed fever). Centralblatt für Bacteriologie 1892; 11: 699– 700.

13. Metchnikoff E. Prolongation of life – Optimistic Studies. New York: Putnam & Sons 1908.

14. van Minnen LP. Acute pancreatitis – Surgery, pathophysiology, probiotic prophylaxis. Enschede: Gildeprint Drukkerijen BV 2006.

15. Oláh A, Belágyi T, Issekutz A et al. Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg 2002; 89: 1103– 1107.

16. Timmerman HM, Koning CJ, Mulder L et al. Monostrain, multistrain and multispecies probiotics. A comparison of functionality and efficacy. Int J Food Microbiol 2004; 96: 219– 233.

17. Besselink MG, van Santvoort HC, Buskens E et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double‑blind, placebo‑ controlled trial. Lancet 2008; 371: 651– 659.

18. Lata J, Juránková J, Stibůrek O et al. Probiotika u akutní pankreatitidy – randomizovaná, placebem kontrolovaná, dvojitě slepá studie. Vnitř Lék 2010; 56: 111– 114.

19. Jafri NS, Mahid SS, Idstein SR et al. Antibiotic prophylaxis is not protective in severe acute pancreatitis: a systematic review and meta‑analysis. Am J Surg 2009; 197: 806– 813.

20. Pezzilli R. Antibiotic prophylaxis in severe acute pancreatitis: do we need more meta‑analytic studies? JOP 2009; 10: 223– 224.